NASDAQ:PBAXU Phoenix Biotech Acquisition (PBAXU) Stock Price, News & Analysis → Biotech's Best Kept Secret: Potential 46,751% Gain (From Behind the Markets) (Ad) Free PBAXU Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.37▼$10.3750-Day Range$10.37▼$10.3752-Week Range$9.82▼$11.73Volume7 shsAverage Volume533 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisTrendsStock AnalysisTrends Get Phoenix Biotech Acquisition alerts: Email Address Ad Porter & CompanyThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. About Phoenix Biotech AcquisitionPhoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.Read More Ad Porter & CompanyThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. PBAXU Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive PBAXU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phoenix Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinancial Services Industry Shell Companies Sub-IndustryN/A Current SymbolNASDAQ:PBAXU CUSIPN/A CIK1870404 Webwww.phoenixbiotechacquisitioncorp.com Phone215-731-9450FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Christopher B. Ehrlich M.B.A. (Age 54)CEO & Director Dr. Douglas Carl Fisher M.B.A. (Age 48)M.D., President Mr. Daniel E. Geffken M.B.A. (Age 67)Chief Financial Officer Key Competitors99 Acquisition GroupNASDAQ:NNAGU99 Acquisition GroupNASDAQ:NNAGWA SPAC II AcquisitionNASDAQ:ASCBWA SPAC II AcquisitionNASDAQ:ASCBUAce Global Business AcquisitionNASDAQ:ACBAWView All Competitors PBAXU Stock Analysis - Frequently Asked Questions When did Phoenix Biotech Acquisition IPO? Phoenix Biotech Acquisition (PBAXU) raised $155 million in an initial public offering on Wednesday, October 6th 2021. The company issued 15,500,000 shares at $10.00 per share. This page (NASDAQ:PBAXU) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phoenix Biotech Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.